Login Register
English
0

Cart

$ 0

EliKine™ Human IL-1β ELISA Kit – the new addition to Abbkine’s scientific research kit family

Date:2017-11-02 Views:14007

EliKine™ Human IL-1β ELISA Kit – the new addition to Abbkine’s scientific research kit familyThe EliKine™ Human IL-1β ELISA Kit is one of the latest scientific research products from Abbkine Scientific Co. Ltd. The company recently announced the launch of the product, designed to enhance scientific research processes.

The IL-1β is a member of the interleukin 1 cytokine family, produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). Interleukin 1β is an important mediator of the inflammatory response, involved in several cellular activities, including cell proliferation, differentiation, and apoptosis.

Interleukin 1β Elisa kit has human reactivity, employing a two-site sandwich ELISA to quantitate IL-1β in samples. The IL1B Elisa kit uses colorimetric method of detection, with the suitable samples types being Cell culture supernatants, other biological fluids, Plasma, and Serum.

The components of the kit include:

  • Human IL-1β microplate
  • Human IL-1β standard
  • Human IL-1β detect antibody
  • EliKine™ Streptavidin-HRP
  • Standard diluent
  • Assay buffer
  • HRP substrate
  • Stop solution
  • Wash buffer
  • Plate covers.

One of the major features and benefits of the kit is its high sensitivity and excellent specificity for detection of Human IL-1β., with no significant cross-reactivity or interference between Human IL-1β and analogues.

About Abbkine Scientific Co. Ltd

Abbkine Scientific Co. Ltd was founded in 2012 by a team of scientists and marketing experts in the life science field in California, USA. Headquartered in China, Abbkine has effectively combined cutting edge technology from United States with China's manufacturing engineering and cost advantages to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research and drug discovery.